SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 30, 16:00
1799.30
13.45 (0.75%)
VOLUME 12,957
LIVE
NSE
Sep 30, 17:00
1800.35
9.8 (0.55%)
VOLUME 307,809
News on Divis Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy AB Nuvo, Divis Labs; sell IRB Infra: Sukhani 

3.29 pm | 24 Sep 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Aditya Birla Nuvo and Divis Labs and advises selling IRB Infra....

Super Six stocks you can bet on September 3 

8.23 am | 03 Sep 2014 |  Source: CNBC-TV18

Hemen Kapadia of KR Choksey Securities advises selling Mahindra and Mahindra with a target of Rs 1376 and buying Divis Lab with a target of Rs 1619....

Buy India Cements, Titan Company, Divis Labs: Vishal Malkan 

12.29 pm | 27 Aug 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com recommends buying Divis Laboratories with a target of Rs 1625 and Titan Company with a target of Rs 395....

Bull's Eye: Buy Kaveri Seed, Tata Chemicals, Greaves Cotton

8.49 am | 27 Aug 2014 |  Source: CNBC-TV18

Vishal B Malkan, malkansview.com advises buying Tata Chemicals for a target price of Rs 400 and India Cements for a target price of Rs 115. ...

Divis Laboratories: Outcome of AGM

8.55 pm | 26 Aug 2014 |  Source: Moneycontrol.com

Divis Laboratories has informed that the 24th Annual General Meeting (AGM) of the Company was held on August 25, 2014....

Logic behind big bang spike in pharma stocks

3.25 pm | 26 Aug 2014 |  Source: Moneycontrol.com

According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high lo...

Bull's Eye: JP Associates, Tech Mahindra, Aurobindo Pharma 

8.49 am | 26 Aug 2014 |  Source: CNBC-TV18

Vishal Jajoo, Nirmal Bang Securities advises buying Kopran for a target price of Rs 65.50 and Jaiprakash Associates for a target price of Rs 55.75....

Buy Divis Labs; target of Rs 1795: ICICIdirect

2.42 pm | 25 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1795 in its August 25, 2014 research ...

Buy Divis Labs; target of Rs 1633: ICICIdirect

2.45 pm | 21 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1633 in its August 15, 2014 research ...

Buy Divis Labs, Canara Bank, Corormandel Intl: AK Prabhakar 

12.07 pm | 21 Aug 2014 |  Source: CNBC-TV18

AK Prabhakar, independent advisor is of the view that one can buy Coromandel International with a long term target of Rs 400 and feels that Mirza Inte...

Buy Divis Laboratories: Sudarshan Sukhani 

10.03 am | 21 Aug 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Divis Laboratories....

Bull's Eye: Buy FDC, CCL Products, Canara Bank, HCL Info 

8.55 am | 21 Aug 2014 |  Source: CNBC-TV18

Nooresh Mirani of Analyse India advises buying FDC for a target price of Rs 170 and HCL Infosystems for a target price of Rs 95....

Check Out: Super Six stocks for August 21 

8.29 am | 21 Aug 2014 |  Source: CNBC-TV18

Hemen Kapadia of KR Choksey Securities suggests buying Divis Laboratories with a target of Rs 1537 and selling LIC Housing Finance with a target of Rs...

Hold Divis Laboratories; target of Rs 1430: Emkay

2.43 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended hold rating on Divis Laboratories with a target price of Rs 1430, in its research report dated August ...

Buy Divis Labs; target of Rs 1425: ICICIdirect

12.27 pm | 28 May 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1425 in its May 27, 2014 research rep...

Buy Divis Laboratories; target of Rs 1419: Emkay

11.05 am | 28 May 2014 |  Source: Moneycontrol.com

Brokerage house Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs...

Divis Labs consolidated Mar '14 sales at Rs 750.21 crore

2.05 pm | 27 May 2014 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 750.21 crore and a net profit of Rs 196.43 crore for the quarter ended Mar '14...

Buy Divis Laboratories; target of Rs 1500: Sharekhan

11.57 am | 27 May 2014 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1500 in its May 26, 2014 research report....

Accumulate Divis Labs; target of Rs 1483: Dolat Capital

5.02 pm | 26 May 2014 |  Source: Moneycontrol.com

Dolat Capital is bullish on Divis Laboratories and has recommended accumulate rating on the stock with a target of Rs 1483 in its May 26, 2014 researc...

Buy Divis Labs; target of Rs 1484: Karvy Stock Broking

12.37 pm | 26 May 2014 |  Source: Moneycontrol.com

Karvy Stock Broking is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1484 in its May 26, 2014 research...

1 2 3
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.